PortfoliosLab logoPortfoliosLab logo
SURI vs. CANC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SURI vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Simplify Propel Opportunities ETF (SURI) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both stocks are quite close, with SURI having a 18.51% return and CANC slightly lower at 17.64%.


SURI

1D
1.28%
1M
8.01%
6M
15.18%
YTD
18.51%
1Y
38.48%
3Y*
9.85%
5Y*
10Y*

CANC

1D
-0.22%
1M
8.97%
6M
12.90%
YTD
17.64%
1Y
57.55%
3Y*
103.96%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SURI vs. CANC - Yearly Performance Comparison


2026 (YTD)202520242023
SURI
Simplify Propel Opportunities ETF
18.51%28.32%-13.34%-2.87%
CANC
Tema Oncology ETF
17.64%42.92%-5.37%367.55%

Correlation

The correlation between SURI and CANC is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.52

Correlation (3Y)
Calculated over the trailing 3-year period

0.59

Correlation (All Time)
Calculated using the full available price history since Feb 8, 2023

0.52

The correlation between SURI and CANC has been stable across timeframes, ranging from 0.52 to 0.59 - a consistent structural relationship.

SURI vs. CANC - Sectors Allocation Comparison


Sectors
SURI
CANC

Healthcare

56.5%
100.0%

Energy

43.5%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

SURI
56.5%
CANC
100.0%

Energy

SURI
43.5%
CANC

-

Basic Materials

SURI

-

CANC

-

Communication Services

SURI

-

CANC

-

Consumer Cyclical

SURI

-

CANC

-

Consumer Defensive

SURI

-

CANC

-

Financial Services

SURI

-

CANC

-

Industrials

SURI

-

CANC

-

Real Estate

SURI

-

CANC

-

Technology

SURI

-

CANC

-

Utilities

SURI

-

CANC

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SURI vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURI
SURI Risk / Return Rank: 6565
Overall Rank
SURI Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
SURI Sortino Ratio Rank: 6363
Sortino Ratio Rank
SURI Omega Ratio Rank: 5959
Omega Ratio Rank
SURI Calmar Ratio Rank: 7979
Calmar Ratio Rank
SURI Martin Ratio Rank: 6161
Martin Ratio Rank

CANC
CANC Risk / Return Rank: 9191
Overall Rank
CANC Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
CANC Sortino Ratio Rank: 9292
Sortino Ratio Rank
CANC Omega Ratio Rank: 8585
Omega Ratio Rank
CANC Calmar Ratio Rank: 9595
Calmar Ratio Rank
CANC Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SURI vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Simplify Propel Opportunities ETF (SURI) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SURICANCDifference
Sharpe ratioReturn per unit of total volatility

-0.83

Sortino ratioReturn per unit of downside risk

-1.22

Omega ratioGain probability vs. loss probability

1.29

1.40

-0.12

Calmar ratioReturn relative to maximum drawdown

3.28

6.22

-2.94

Martin ratioReturn relative to average drawdown

8.68

16.88

-8.20

SURI vs. CANC - Sharpe Ratio Comparison

The current SURI Sharpe Ratio is 1.72, which is lower than the CANC Sharpe Ratio of 2.54. The chart below compares the historical Sharpe Ratios of SURI and CANC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SURI vs. CANC - Drawdown Comparison

The maximum SURI drawdown since its inception was -47.76%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for SURI and CANC.


Loading charts...

Drawdown Indicators


SURICANCDifference

Max Drawdown

Largest peak-to-trough decline

-47.76%

-97.53%

+49.77%

Max Drawdown (1Y)

Largest decline over 1 year

-11.78%

-9.30%

-2.48%

Max Drawdown (3Y)

Largest decline over 3 years

-47.76%

-30.27%

-17.49%

Current Drawdown

Current decline from peak

-7.80%

-51.23%

+43.43%

Average Drawdown

Average peak-to-trough decline

-17.21%

-72.69%

+55.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.45%

3.42%

+1.03%

Volatility

SURI vs. CANC - Volatility Comparison

The current volatility for Simplify Propel Opportunities ETF (SURI) is 5.76%, while Tema Oncology ETF (CANC) has a volatility of 6.30%. This indicates that SURI experiences smaller price fluctuations and is considered to be less risky than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SURICANCDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.76%

6.30%

-0.54%

Volatility (6M)

Calculated over the trailing 6-month period

14.78%

16.42%

-1.64%

Volatility (1Y)

Calculated over the trailing 1-year period

22.51%

22.73%

-0.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.07%

277.03%

-248.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.07%

277.03%

-248.96%

SURI vs. CANC - Expense Ratio Comparison

SURI has a 2.51% expense ratio, which is higher than CANC's 0.75% expense ratio.


Dividends

SURI vs. CANC - Dividend Comparison

SURI's dividend yield for the trailing twelve months is around 14.95%, more than CANC's 0.05% yield.


PositionTTM202520242023
CANC
Tema Oncology ETF
0.05%0.06%3.00%0.56%
SURI
Simplify Propel Opportunities ETF
14.95%16.31%21.41%14.71%

Frequently Asked Questions


SURI and CANC have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CANC has higher volatility (6.30%) compared to SURI (5.76%). In terms of maximum drawdown, SURI dropped -47.76% vs CANC's -97.53%.

On 3-year performance, CANC leads with 103.96% vs 9.85% for SURI. On fees, CANC is cheaper at 0.75% per year. On volatility, SURI has been the lower-risk option at 5.76%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, CANC has performed better with a 103.96% return vs 9.85%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CANC is cheaper with a 0.75% expense ratio, compared with 2.51% for SURI.

SURI has the higher dividend yield at 14.95%, compared with 0.05% for CANC.

They also come from different issuers: Simplify and Tema. Their fees differ too: 2.51% for SURI and 0.75% for CANC.

CANC currently has the higher Sharpe Ratio (2.54 vs 1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SURI and CANC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer